Kitazato Corporation (TYO:368A)

Market Cap	48.04B
Revenue (ttm)	10.95B +6.3%
Net Income	3.90B +2.8%
EPS	97.38 +2.8%
Shares Out	40.00M
PE Ratio	12.33
Forward PE	12.01
Dividend	41.00 (3.40%)
Ex-Dividend Date	Mar 30, 2026

Volume	84,100
Open	1,207.00
Previous Close	1,207.00
Day's Range	1,201.00 - 1,222.00
52-Week Range	1,157.00 - 2,158.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 25, 2026

About Kitazato

Kitazato Corporation researches, develops, manufactures, and markets medical devices and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company was formerly known as Kitazato Biopharma Co., Ltd. The company was founded in 1998 and is based in Shizuoka, Japan. Kitazato Corporation is a subsidiary of Kitasato Shoji Co., Ltd.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Employees: 86
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 368A

Financial Performance

In fiscal year 2026, Kitazato's revenue was 10.95 billion, an increase of 6.26% compared to the previous year's 10.30 billion. Earnings were 3.90 billion, an increase of 2.82%.